INOVIO PHARMACEUTICALS INC's ticker is and the CUSIP is 45773H951. A total of 6 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,828 | -46.8% | 4,700 | -39.0% | 0.00% | – |
| Q2 2023 | $3,438 | -70.3% | 7,700 | -45.4% | 0.00% | – |
| Q1 2023 | $11,562 | -89.6% | 14,100 | -80.2% | 0.00% | – |
| Q4 2022 | $111,228 | -48.3% | 71,300 | -42.8% | 0.00% | – |
| Q3 2022 | $215,000 | -24.3% | 124,700 | -24.1% | 0.00% | – |
| Q2 2022 | $284,000 | -74.7% | 164,300 | -47.4% | 0.00% | -100.0% |
| Q1 2022 | $1,122,000 | +79.8% | 312,500 | +149.8% | 0.00% | 0.0% |
| Q4 2021 | $624,000 | -47.5% | 125,100 | -24.7% | 0.00% | 0.0% |
| Q3 2021 | $1,189,000 | -8.7% | 166,100 | +18.2% | 0.00% | -50.0% |
| Q2 2021 | $1,302,000 | -38.9% | 140,500 | -38.8% | 0.00% | -33.3% |
| Q1 2021 | $2,131,000 | -2.3% | 229,600 | -6.9% | 0.00% | -25.0% |
| Q4 2020 | $2,182,000 | -47.5% | 246,500 | -31.3% | 0.00% | -69.2% |
| Q3 2020 | $4,160,000 | -39.6% | 358,600 | +40.4% | 0.01% | -59.4% |
| Q2 2020 | $6,886,000 | +882.3% | 255,500 | +171.2% | 0.03% | +433.3% |
| Q1 2020 | $701,000 | +580.6% | 94,200 | +201.0% | 0.01% | +500.0% |
| Q4 2019 | $103,000 | +114.6% | 31,300 | +34.9% | 0.00% | – |
| Q3 2019 | $48,000 | -57.5% | 23,200 | -39.7% | 0.00% | -100.0% |
| Q2 2019 | $113,000 | -5.0% | 38,500 | +21.1% | 0.00% | 0.0% |
| Q1 2019 | $119,000 | +91.9% | 31,800 | +105.2% | 0.00% | 0.0% |
| Q4 2018 | $62,000 | -56.6% | 15,500 | -39.7% | 0.00% | 0.0% |
| Q3 2018 | $143,000 | 0.0% | 25,700 | -29.6% | 0.00% | 0.0% |
| Q2 2018 | $143,000 | +376.7% | 36,500 | +479.4% | 0.00% | – |
| Q1 2018 | $30,000 | +3.4% | 6,300 | -11.3% | 0.00% | – |
| Q4 2017 | $29,000 | -90.9% | 7,100 | -85.8% | 0.00% | -100.0% |
| Q3 2017 | $318,000 | +329.7% | 50,100 | +433.0% | 0.00% | +200.0% |
| Q2 2017 | $74,000 | +184.6% | 9,400 | +135.0% | 0.00% | – |
| Q1 2017 | $26,000 | -95.0% | 4,000 | -94.6% | 0.00% | -100.0% |
| Q4 2016 | $515,000 | -54.4% | 74,200 | -38.7% | 0.01% | -58.3% |
| Q3 2016 | $1,129,000 | +9.7% | 121,100 | +8.7% | 0.01% | 0.0% |
| Q2 2016 | $1,029,000 | +21.9% | 111,400 | +15.0% | 0.01% | 0.0% |
| Q1 2016 | $844,000 | -43.4% | 96,900 | -56.3% | 0.01% | -33.3% |
| Q4 2015 | $1,491,000 | +25.9% | 221,800 | +8.2% | 0.02% | +12.5% |
| Q3 2015 | $1,184,000 | -19.9% | 204,900 | +13.1% | 0.02% | -23.8% |
| Q2 2015 | $1,478,000 | +424.1% | 181,100 | +424.9% | 0.02% | +425.0% |
| Q1 2015 | $282,000 | -72.1% | 34,500 | -68.7% | 0.00% | -73.3% |
| Q4 2014 | $1,012,000 | -71.7% | 110,200 | -69.7% | 0.02% | -72.7% |
| Q3 2014 | $3,578,000 | – | 363,200 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JPMORGAN CHASE & CO | 255,000 | $441,000 | 0.00% |
| SIMPLEX TRADING, LLC | 42,200 | $73,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JANE STREET GROUP, LLC | 21,100 | $37,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 164,300 | $284,000 | 0.00% |